Please enable Javascript
The HemOnc Pulse
Meeting News
The HemOnc Pulse Live
Video Insights
In Print
Subscribe
Leukemia
Acute Lymphoblastic Leukemia
Acute Myeloid Leukemia
Chronic Lymphocytic Leukemia
Chronic Myeloid Leukemia
Lymphoma
Aggressive B-Cell Lymphoma
Hodgkin Lymphoma
Indolent B-Cell Lymphoma
Mantle Cell Lymphoma
T-Cell Lymphoma
MPN
Myelofibrosis
Polycythemia Vera
MDS
Myeloma
Transplantation & Cellular Therapy
oral regimen
Oral Triplet Regimen Performs Better Than Doublet in Patients with Myeloma Progressing on Frontline Lenalidomide
Cecilia Brown
Meeting News
|
November 22, 2022
Adding ixazomib to pomalidomide and dexamethasone improved progression-free survival rates...
Read More
All-Oral, Chemo-Free Regimen Provides Durable Response in Frontline CLL Setting
Kerri Fitzgerald
Chronic Lymphocytic Leukemia
|
February 1, 2023
Three-year follow-up data from the CAPTIVATE trial were presented at the 2022 ASCO Annual Meeting.
Read More
Advertisement
Advertisement
Advertisement
Advertisement